KAYS to report to shareholders on Q-2 results of operations,
progress of medical
cannabis
cultivation
projects
in Greece and Israel,
and
other
business developments
Fort
Lauderdale, Florida --
August 25,
2020 -- InvestorsHub NewsWire -- Kaya
Holdings, Inc., ("KAYS"
or the
"Company")
(OTCQB:KAYS),
the first U.S. publicly traded company to vertically integrate
cannabis retail, cultivation and processing
operations announced
today that
it has scheduled and commenced issuing reservation codes for an
Online Shareholder Business Update, which is to be held on
Wednesday,
September 2, 2020
at 2:00 PM Eastern Time.
Seating is limited so
please register now using the following
link
to
reserve your place for the program:
https://us02web.zoom.us/webinar/register/WN_fdKpjk8oTnWZeOzIwc2klw
After registering,
you will receive a confirmation email containing information about
joining the webinar. If you do not receive a confirmation
email, please
contact
us via email at info@kayaholdings.com and we will assist
you.
Participants
will be
able to view the presentation live on their
computer, tablet
or
smartphone. The presentation is expected to last between 60-90
minutes and will
feature
online live discussion with Craig Frank, KAYS Chairman
and
CEO and
W. David Jones, Senior Advisor for Business Development and
Financial Operations, as well as live onsite reports from
Management and
Staff in
Oregon,
Greece
and Israel.
Topics
to be
covered will include:
-
Results
of Financial Operations for the three and six
month periods
ending
June 30, 2020, as reported on KAYS
recently filed Form 10-Q.
-
Reports
on progress of our subsidiary Kaya Brands
International, Inc.'s medical marijuana
cultivation projects in Greece and Israel.
These two
facilities, as currently envisioned (and after obtaining successful
financing, completing construction and obtaining final requisite
licensing), are configured to produce approximately 600,000 pounds
of GMP Certified, Premium Medical Grade, Cannabis annually for
potential export to the European Union and elsewhere.
-
Other
general business developments.
"We have spent the
last two
years
planning
on the expansion of our business by developing
international
opportunities for
KAYS. Management had determined that
international projects would enable KAYS to leverage its 6+ years
in the U.S. cannabis industry to foster growth and
build
increase shareholder value," stated KAYS CEO
Craig Frank. "We look forward on
reporting KAYS' progress shareholders."
About Kaya Holdings, Inc. (www.kayaholdings.com)
Kaya
Holdings, Inc. ("KAYS") is a touch-the-plant vertically integrated
legal cannabis company operating a number of majority-owned
subsidiaries that retail, cultivate, produce and distribute premium
medical and recreational cannabis products, including flower,
concentrates, oils and extracts, cannabis-infused foods and
beverages, topicals and cannaceuticals.
KAYS is a fully reporting, US-based publicly traded company, listed
for trading on the OTCQB Tier of the over-the-counter market under
the symbol
OTCQB:KAYS.
Summary
of Operations
KAYS corporate
structure includes the following three majority-owned subsidiaries,
each responding to various demands and opportunities in the
cannabis industry:
Marijuana Holdings Americas, Inc. owns
the Kaya Shack™ brand of licensed medical and recreational
marijuana stores (www.kayashack.com)
and the Kaya Farms™ brand of cannabis production and processing
operations that operate in the United States.
Kaya Brands USA, Inc. owns
a wide range of proprietary brands of cannabis extracts, oils,
pre-rolls, topicals, food and beverages, cannaceuticals
and
related accessories.
Kaya Brands International, Inc., was
founded to serve as the vehicle for the Company's non-U.S.
operations including retail franchising in Canada and cultivation
activities in Greece and Israel.
Marijuana Holdings Americas, Inc.- U.S. Cannabis
Operations
Kaya Shack™ Retail Cannabis Stores
In
2014, KAYS became the first United States publicly-traded company
to own and operate a Medical Marijuana Dispensary. KAYS
presently operates
two
Kaya Shack™ OLCC licensed marijuana retail stores to service the
legal medical and recreational marijuana market in Oregon, and is
in the process of relocating a third retail cannabis license to
serve as a delivery hub for the Eugene and Southern Oregon Cannabis
Market.
Kaya Farms™
Eugene, Oregon Indoor Grow, Processing &
Cannaceutical
Facility: The
Company owns a 12,000 square foot Kaya Farms™ indoor grow and
manufacturing facility in Eugene, Oregon, which
serves as the Company's center for cultivation trials, method
experiments, genetic research and cannabis infused product
development. The Company is presently conducting limited operations
at this location under a Management Agreement with Sunstone Farms,
the current licensee. Pending the successful acquisition and
transfer of other existing OLCC Marijuana Production and Processing
licenses, KAYS intends to build out the facility and ramp up to
full production.
Lebanon, Oregon Farm & Greenhouse Facility: KAYS
owns a 26-acre parcel in Lebanon, Linn County, Oregon which it
intends to construct an 85,000-square-foot Kaya Farms™ greenhouse
cultivation and production facility. To date KAYS has received Linn
County Zoning approvals and upon issuance of OLCC Licensing it will
begin construction. The farm is intended for immediate development
and provides the Company with a potential additional capacity of
more than 100,000 pounds annually, to be expanded once export from
Oregon to other U.S. States and foreign countries where cannabis
use is legal is permitted. Kaya Farms™ operates in accordance with
a Grow Operations manual, as well as manuals for compliance,
employment matters and safety.
Kaya Brands USA, Inc.- Brand and Product Development
The
Company maintains a genetics library of over 30 strains of cannabis
and owns a number of proprietary brands in traditional and
innovative cannabis categories including Kaya Buddies™ pre-rolls,
Really Happy Glass™ cannabis accessories, and Kaya Gear™,
company-related and cannabis-centric fashion. These brands are
currently available at Kaya Shack™ stores.
The
Company has made advances in the development of its
Kumba
Extracts™,
Syzygy Extracts™, Pakalolo Juice Company™ Soothe Topicals™, Tony
Giggles Pleasure Foods™ (frozen infused Italian entrees), Uptown
Shaman™ (cannaceuticals),
and Kaya Yums™
(chocolates, gummies, power bars) brands. Pending approval of our
production and processing license, KAYS intends to begin a
multi-state rollout planned in 2020 to the extent permitted by U.S.
legal infrastructure. These brands are intended for all Kaya Shack™
stores, both corporate-owned and franchised.
Kaya Brands International, Inc.- Foreign Cannabis
Operations
After
over six years of conducting "touch the plant" U.S. cannabis
operations inside the strict regulatory confines of a public
company, KAYS has formed a subsidiary, Kaya Brands International,
Inc. ("KBI") to leverage its experience and expand into worldwide
cannabis markets. KBI's current operations and initiatives
include:
Kaya
Kannabis-
Kaya Farms™ Greece S.A.
("Kaya Farms Greece", a Greek Corporation) is a
majority owned subsidiary of KBI. The Company is in the final
stages of completing their due diligence and expects to exercise
their option (pursuant to terms of a previously disclosed 8-K
filing) for Kaya Farms Greece to acquire a 50% interest in
Greekkannabis,
PC, an Athens, Greece based cannabis company which has received its
license for the construction of a facility encompassing
approximately 500,000 square feet of buildings on 15 acres of land
outside of Athens, Greece to grow, process and export medical grade
cannabis from Greece to the European Union and
elsewhere.
Kaya Farms™ Israel-
Kaya Shalvah
LTD
("Kaya Farms Israel", an Israeli Corporation) is
a majority owned subsidiary of KBI. Kaya Farms Israel is in the
process of applying to various Israeli Government Agencies for a
license to grow, process and export medical grade cannabis from
Israel. Upon submission of the initial application to the Israeli
Cannabis Authority, Kaya Shalvah
intends
to submit a bid to acquire 100 Dunams (approximately 25 acres) of
land in Israel that is part of Greenegev,
an Israeli Government backed Cannabinoid Ecosystem in
Yerucham,
Israel that is envisioned to become the Silicon Valley of Medical
Cannabis Production and Research
These two facilities, as currently envisioned
(and
after obtaining successful financing, completing construction and
obtaining final requisite licensing),
are configured to produce approximately 600,000 pounds of GMP
Certified,
Premium
Medical
Grade,
Cannabis annually for potential export to the European Union and
elsewhere.
Canadian Franchising: KAYS
has targeted Canada (the only G7 country that has legalized both
medical and recreational cannabis production, sale and use on a
national level) for its first international sale and operation of
Kaya Shack™ cannabis store franchises, with a goal of 75-100 Kaya
Shack™ Cannabis Retail locations throughout Canada through a
multi-year structured rollout, subject to licensing and market
conditions. KAYS has retained Toronto, Canada based law firm of
Garfinkle Biderman,
LLP to prepare the Franchise Disclosure Documents and related items
for the sale of Kaya Shack™ cannabis store franchises in Canada.
KAYS plans
to
ultimately expand its franchise operations to the U.S., as
regulations and laws permit.
Important Disclosure
KAYS
is planning execution of its stated business objectives in
accordance with current understanding of state and local laws and
federal enforcement policies and priorities as it relates
to
marijuana. Potential investors and shareholders are cautioned that
KAYS and MJAI will obtain advice of counsel prior to actualizing
any portion of their business plan (including but not limited to
license applications for the cultivation, distribution or sale of
marijuana products, engaging in said activities or acquiring
existing cannabis production/sales operations). Advice of counsel
with regard to specific activities of KAYS, federal, state or local
legal action or changes in federal government policy and/or state
and local laws may adversely affect business operations and
shareholder value.
Forward Looking Statements
This
press release includes statements that may constitute
"forward-looking" statements, usually containing the words
"believe," "estimate," "project," "expect" or similar statements
are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. Factors that would cause or contribute to such
differences include, but are not limited to, acceptance of the
Company's current and future products and services in the
marketplace, the ability of the Company to develop effective new
products and receive regulatory approvals of such products,
competitive factors, dependence upon third-party vendors, and other
risks detailed in the Company's periodic report filings with the
Securities and Exchange Commission. By making these forward-looking
statements, the Company undertakes no obligation to update these
statements for revisions or changes after the date of this
release.
For
more information contact Investor Relations:
561-210-7664
SOURCE: Kaya
Holdings, Inc.
Kaya (QB) (USOTC:KAYS)
Historical Stock Chart
From Apr 2024 to May 2024
Kaya (QB) (USOTC:KAYS)
Historical Stock Chart
From May 2023 to May 2024